DK569087D0 - Quinolin-derivater, deres fremstilling og anvendelse - Google Patents

Quinolin-derivater, deres fremstilling og anvendelse

Info

Publication number
DK569087D0
DK569087D0 DK569087A DK569087A DK569087D0 DK 569087 D0 DK569087 D0 DK 569087D0 DK 569087 A DK569087 A DK 569087A DK 569087 A DK569087 A DK 569087A DK 569087 D0 DK569087 D0 DK 569087D0
Authority
DK
Denmark
Prior art keywords
preparation
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
DK569087A
Other languages
English (en)
Other versions
DK569087A (da
Inventor
Hajime Kawakami
Renzo Ohuchi
Masahumi Kitano
Keiichi Ono
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61310931A external-priority patent/JPS63166881A/ja
Priority claimed from JP62119685A external-priority patent/JPS63264485A/ja
Priority claimed from JP62119686A external-priority patent/JPS63225358A/ja
Priority claimed from JP62119687A external-priority patent/JPS63239271A/ja
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of DK569087D0 publication Critical patent/DK569087D0/da
Publication of DK569087A publication Critical patent/DK569087A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK569087A 1986-10-31 1987-10-30 Quinolin-derivater, deres fremstilling og anvendelse DK569087A (da)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP26158086 1986-10-31
JP26157986 1986-10-31
JP26298386 1986-11-05
JP61310931A JPS63166881A (ja) 1986-12-29 1986-12-29 アミノアザアクリジン誘導体
JP31093086 1986-12-29
JP7848387 1987-03-30
JP62119685A JPS63264485A (ja) 1986-12-29 1987-05-15 アミノキノリン誘導体
JP62119686A JPS63225358A (ja) 1986-10-31 1987-05-15 シクロペンタ〔ｂ〕キノリン誘導体
JP62119687A JPS63239271A (ja) 1986-11-05 1987-05-15 シクロヘプタ〔ｂ〕キノリン誘導体

Publications (2)

Publication Number Publication Date
DK569087D0 true DK569087D0 (da) 1987-10-30
DK569087A DK569087A (da) 1988-05-01

Family

ID=27577185

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569087A DK569087A (da) 1986-10-31 1987-10-30 Quinolin-derivater, deres fremstilling og anvendelse

Country Status (2)

Country Link
EP (1) EP0268871A1 (da)
DK (1) DK569087A (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
US4897400A (en) * 1987-02-13 1990-01-30 Hoeschst-Roussel Pharmaceuticals, Inc. 9-amino-1,4-ethano-1,2,3,4-tetrahydroacridine and related compounds useful for incresing the cholinergic function in a mammal
FI91401C (fi) * 1987-03-17 1994-06-27 Hoechst Roussel Pharma Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
US4806646A (en) * 1987-03-30 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Substituted 9-amino-spiro[cycloalkyl[B]quinoline-2,1'cycloalkanes]
US6075144A (en) 1987-04-20 2000-06-13 Hoechst Marion Roussel, Inc. 9-hydroxyamino tetrahydroacridine and related compounds
US5013741A (en) * 1987-09-08 1991-05-07 Hoechst-Roussel Pharmaceuticals Incorporated N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal
US5037833A (en) * 1988-07-25 1991-08-06 Hoechst-Roussel Pharmaceuticals Inc. N-[substituted alkylidene]fused-bicycloalkylidene quinolinamines useful for enhancing the cholinergic function in a mammal
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
US5008853A (en) 1987-12-02 1991-04-16 Xerox Corporation Representation of collaborative multi-user activities relative to shared structured data objects in a networked workstation environment
US4985430A (en) 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
US4868177A (en) * 1988-11-09 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
CA2015282A1 (en) * 1989-04-25 1990-10-25 Renzo Ohuchi Pyridine derivatives
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US4994452A (en) * 1989-11-28 1991-02-19 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
US5112829A (en) * 1989-11-28 1992-05-12 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
DE4039996A1 (de) * 1990-10-31 1992-05-07 Nattermann A & Cie Verfahren zur herstlelung von phosphatidylcholinderivaten
US5155226A (en) * 1991-02-19 1992-10-13 Hoechst-Roussel Pharmaceuticals Incorporated Method for the preparation of 9-amino-1,2,3,4-tetrahydroacridine
RU2024509C1 (ru) * 1991-05-07 1994-12-15 Всероссийский научный центр по безопасности биологически активных веществ Производные 9-аминоакридина или их соли с органическими или неорганическими кислотами, проявляющие психотропную, антиамнестическую и липидрегулирующую активность
ES2042384B1 (es) * 1991-12-26 1994-06-01 Boehringer Ingelheim Espana Procedimiento para obtener derivados bis-piridinicos.
ES2100129B1 (es) * 1995-10-11 1998-02-16 Medichem Sa Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
GB9524346D0 (en) * 1995-11-29 1996-01-31 Univ Strathclyde Polycyclic compounds
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ES2168926B1 (es) * 1999-12-14 2003-10-16 Prous Science S A Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente.
FR2926550B1 (fr) * 2008-01-18 2010-09-10 Centre Nat Rech Scient Derives de tetrahydrocyclopenta°c!acridines inhibiteurs de kinases et leurs applications biologiques
CA2783934A1 (en) 2009-12-11 2011-06-16 Genecode As Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
CA2893468C (en) 2012-12-13 2021-01-12 H. Lundbeck A/S Use of vortioxetine and donepezil in the treatment of cognitive impairment
RU2567388C1 (ru) * 2014-12-10 2015-11-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Способ получения 9-бутиламино-3,3-диметил-3,4-дигидроакридин-1(2н)-она гидрохлорида
WO2016135138A1 (en) 2015-02-23 2016-09-01 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer
WO2016135139A1 (en) 2015-02-23 2016-09-01 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh 2,3-dihydrocyclopenta[b]quinoline derivatives as mth1 inhibitors for the therapy of cancer
WO2016135140A1 (en) 2015-02-23 2016-09-01 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh 4-aminoquinazoline derivatives as mth1 inhibitors for the therapy of cancer
WO2016135137A1 (en) 2015-02-23 2016-09-01 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Substituted 4-(phenylamino)quinoline derivatives as mth1 inhibitors for the therapy of cancer
WO2019207604A1 (en) * 2018-04-25 2019-10-31 Rajiv Gandhi Centre For Biotechnology Tacrine derivatives targeting nmda receptor, acetylcholine esterase, butyryl choline and beta secretase activity
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
CZ202135A3 (cs) * 2021-01-26 2022-06-29 Fakultní nemocnice Hradec Králové Duálně účinné deriváty takrinu a jejich použití

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US3541066A (en) * 1968-09-16 1970-11-17 American Home Prod 2,3-dihydro-1,4-ethanobenzo(b)(1,5)naphthyridine derivatives

Also Published As

Publication number Publication date
EP0268871A1 (en) 1988-06-01
DK569087A (da) 1988-05-01

Similar Documents

Publication Publication Date Title
DK569087A (da) Quinolin-derivater, deres fremstilling og anvendelse
DK514586A (da) Quinolinderivater, deres fremstilling og anvendelse
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK354687D0 (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK633287A (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK235787D0 (da) Tripeptidderivater, deres fremstilling og anvendelse
DK278188A (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK213387D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK212687A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK607787A (da) 12-halogenerede forskolin-derivater, deres fremstilling og anvendelse
DK610787A (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
DK223288D0 (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK548586A (da) Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse
DK412188A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK675687D0 (da) Substituerede n-methylisoxazolidiner, deres fremstilling og anvendelse
DK625287A (da) 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse
DK126987D0 (da) Pyrimidoindoler, deres fremstilling og anvendelse
DK361388A (da) Cephemderivater, deres fremstilling og anvendelse
DK613888D0 (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK377387D0 (da) Tetrahydrobenzothiazolo-quinoliner, deres fremstilling og anvendelse
DK668888D0 (da) Labdan-derivater, deres fremstilling og anvendelse
DK668788D0 (da) Labdanderivater, deres fremstilling og anvendelse
DK727388D0 (da) 2-aminotetrahydroisoquinolinderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn